Your healthcare team needs to assess your overall diabetes control, review your HbA1c levels, and determine whether alternative treatments are necessary
Conclusion A new drug named tirzepatide has been approved to treat T2DM, and it is expected to be approved for weight loss by activating both GLP-1 and GIP receptors through a unique mechanism
Specifically, eligibility requires BMI 30 kg/m independent of other conditions, or BMI 27 kg/m in the presence of at least one weight-related comorbidity such as hypertension, type 2 diabetes, or cardiovascular disease
I mean, with this long COVID and all, great work that Akiko [Iwasaki]s doing and others
To find out more about how your diet can improve your bone health, you might like to read our article: 12 of the best foods for bone health
Cellular Migration & Repair: Explored for combined activity in upregulating actin sequestration (cell motility), modulating inflammatory markers, and accelerating overall wound closure in vitro